OTCMKTS:FLACU Frazier Lifesciences Acquisition (FLACU) Stock Price, News & Analysis $9.50 +0.23 (+2.48%) As of 11/22/2022 Add Compare Share Share Stock Analysis Stock Analysis About Frazier Lifesciences Acquisition Stock (OTCMKTS:FLACU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FLACU alerts:Sign Up Key Stats Today's Range$8.07▼$10.8050-Day Range$9.50▼$9.5052-Week Range$8.07▼$10.80Volume18,300 shsAverage Volume13,949 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewFrazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.Read More… Receive FLACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Frazier Lifesciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address FLACU Stock News HeadlinesGlycoMimetics Enters Into Acquisition Agreement With Crescent BiopharmaOctober 31, 2024 | stockhouse.comGlycoMimetics enters acquisition agreement with Crescent BiopharmaOctober 29, 2024 | markets.businessinsider.comYour chance to get on the next “60-Second Trade”Even retirees are being forced back to work just to keep up. And if you're waiting for help from the Fed or government... Well, you might be waiting a very long time. But Roger Scott has uncovered something interesting... What if there was a way to fight back against inflation? A simple method you could use right from your phone...March 5, 2025 | WealthPress (Ad)Frazier Lifesciences Acquisition Corporation (FLACU)August 5, 2022 | finance.yahoo.comNewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic DiseasesJuly 25, 2022 | finance.yahoo.comAre Institutions Heavily Invested In Frazier Lifesciences Acquisition Corporation's (NASDAQ:FLAC) Shares?July 24, 2022 | finance.yahoo.comFrazier SPAC Is in Talks to Merge With NewAmsterdam PharmaJuly 19, 2022 | finance.yahoo.comFrazier Life Sciences Adds Highly Experienced Biopharmaceutical Executive to TeamFebruary 22, 2022 | tmcnet.comSee More Headlines FLACU Stock Analysis - Frequently Asked Questions How have FLACU shares performed this year? Frazier Lifesciences Acquisition's stock was trading at $9.50 at the beginning of 2025. Since then, FLACU stock has increased by 0.0% and is now trading at $9.50. View the best growth stocks for 2025 here. How do I buy shares of Frazier Lifesciences Acquisition? Shares of FLACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinancial Services Industry Shell Companies Sub-IndustryTrading Current SymbolOTCMKTS:FLACU CIK1828326 Webwww.frazierlifesciencesacquisition.com Phone206 621 7200FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (OTCMKTS:FLACU) was last updated on 3/5/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Frazier Lifesciences Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Frazier Lifesciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
